Untangling the origins of competitive advantage
Iain Cockburn (),
Rebecca M. Henderson and
Strategic Management Journal, 2000, vol. 21, issue 10‐11, 1123-1145
This paper begins to reconcile competing perspectives on the origins of competitive advantage by examining the adoption of ‘science‐driven’ drug discovery, a performance‐enhancing organizational practice. Science‐driven drug discovery diffused slowly, allowing us to disentangle alternative theories of organizational heterogeneity. Adoption is driven by initial conditions, time‐varying internal and external environmental conditions, and convergence (firms positioned least favorably adopt most aggressively). While accounting for initial conditions is critical, managers are sensitive to idiosyncratic environmental cues. The origins of competitive advantage may therefore lie in the ability to identify and respond to environmental cues well in advance of observing performance‐oriented pay‐offs. Copyright © 2000 John Wiley & Sons, Ltd.
References: Add references at CitEc
Citations: View citations in EconPapers (18) Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:bla:stratm:v:21:y:2000:i:10-11:p:1123-1145
Ordering information: This journal article can be ordered from
http://www.blackwell ... bs.asp?ref=0143-2095
Access Statistics for this article
More articles in Strategic Management Journal from Wiley Blackwell
Bibliographic data for series maintained by Wiley Content Delivery ().